• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION STERILE FX25RWC W/ RES; BLOOD GAS OXYGENATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORPORATION STERILE FX25RWC W/ RES; BLOOD GAS OXYGENATOR Back to Search Results
Model Number 3CX*FX25RWC
Device Problem Particulates (1451)
Patient Problem No Patient Involvement (2645)
Event Date 02/14/2018
Event Type  malfunction  
Manufacturer Narrative
Terumo has not received the device for evaluation; therefore, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.For this reason, terumo references evaluation conclusion code.No patient involvement.Particulates.Results pending completion of evaluation.Conclusion not yet available-evaluation in progress.
 
Event Description
The user facility reported to terumo cardiovascular that prior to cardiopulmonary bypass, during inspection at a distributor, there were particulates found inside the oxygenator.No patient involvement.
 
Manufacturer Narrative
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on march 5, 2018.(b)(4).All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
 
Manufacturer Narrative
This follow-up report is submitted to fda in accord with applicable regulations.(b)(4).Upon receipt it was noted that there was a piece of tape with the arrow on the oxygenator to identify the location of the suspected area.The returned sample was thoroughly inspected for the visual defects such as foreign matter or presence of particle with naked eye and under magnification.No anomalies noted anywhere on the returned unit including the identified area by the customer.A retention sample from the same product code/lot number was visually inspected.No anomalies noted.All capiox fx units subjected to several visual inspections during the manufacturing process, up until it is packaged into the one-piece box.The reported event was not able to confirmed therefore the actual root cause cannot be determined.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STERILE FX25RWC W/ RES
Type of Device
BLOOD GAS OXYGENATOR
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
125 blue ball road
elkton MD 21921
MDR Report Key7313817
MDR Text Key101705164
Report Number1124841-2018-00036
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
PMA/PMN Number
K151791
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup,Followup
Report Date 04/24/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date06/30/2020
Device Model Number3CX*FX25RWC
Device Catalogue NumberN/A
Device Lot NumberVH17
Other Device ID Number(01)00699753450837
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/01/2018
Initial Date Manufacturer Received 02/14/2018
Initial Date FDA Received03/05/2018
Supplement Dates Manufacturer Received03/01/2018
04/19/2018
Supplement Dates FDA Received03/20/2018
04/24/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-